Phase 2 Results Of Genasense(R) Plus Chemotherapy In Advanced Prostate Cancer Reported At Cancer Conference

Sat, 24 Feb 2007 02:00 PM EST

... Genta Incorporated (Nasdaq: GNTA) announced preliminary results from a Phase 2 study of Genasense(R) (oblimersen sodium) Injection plus chemotherapy in patients with advanced prostate cancer. This randomized open-label trial was conducted by the European Organisation for Research and Treatment of Cancer (EORTC). Dr. Cora N. [click link for full article] ...